Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 409-414

  Sanjeei, C B ^a,f   Hjelmstrom P ^a   Hallmans, G ^b   Wiklund, F ^e   Lenner, P ^e   Angstrom T ^e   Dillner, J ^c   Lernmark, A ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; FEMALE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; SEROLOGY; UTERINE CERVIX DYSPLASIA;

ADULT; ALLELES; ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 0029807161     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<409::AID-IJC1>3.3.CO;2-P     Document Type: Article

References (28)

1. AMIEL, J., A study of leukocyte phenotype in Hodgkin's disease. In: P. Terasaki (ed.), Histocompatibility testing, p. 79, Munksgaard, Copenhagen (1967).
2. APPLE, R., BECKER, T., WHEELER, C. and ERLICH, H., Comparison of HLA DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J. nat. Cancer Inst., 87, 427-436 (1995).
3. APFLE, R., ERLICH, H., KLITZ, W., MANOS, M., BECKER, T. and WHEFLER, C., HLA DR-DQ associations with cervical carcinoma show papillomavirus type specificity. Nature Genet., 6, 157-162 (1994).
4. CHUA, K.L., WIKLUND, F., LENNER, P., ENGSTRÖM, T., HALLMANS, G., SAPP, M., SCHILLER, J., BERGMAN, F., WADELL, G., HJERPE, A. and DILLNER, J., A prospective study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in cervical smears, Int. J. Cancer, in press (1946).
5. DILLNER, J., Serology of human papillomavirus. Cancer J., 8, 264-268 (1995).
6. DILLNER, J., LENNER, P., LEHTINEN, M., EKLUND, C., HEINO, P., WIKLUND, F., HALLMANS, G. and STENDHAL, U., A population-based seroepidemiological study of cervical cancer. Cancer Res., 54, 134-141 (1994).
7. DILLNER, J., WIKLUND, F., LENNER, P., EKLUND, C., FREDRIKSSON-SHANAZARIAN, V., SCHILLER, J., HIBMA, G., HALLMANS, G. and STENDHAL, U., Antiodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer, 60, 377-382 (1995).
8. ERLICH, H.A. and BUGAWAN, B.L., HLA class-II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In: H.A. Erlich (ed.), PCR technology - principles and applications for DNA amplification, pp. 193-208, Stockton, New York (1989).
9. EVANDER, M., EDLUND, K., GUSTAFFSON, A., JONSSON, M., KARLSSON, R., RYDLANDER, E. and WADELL, G., Human papillomavirus infection is transient in young women: a population-based cohort study. J. infect. Dis., 171, 1026-1030 (1995).
10. GLEW, S., DUGGAN-KEEN, M., GHOSH, A., IVINSON, A., SINNOT, P., DAVIDSON, J., DYER, P. and STERN, P., Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum. Immunol., 37, 157-164 (1993).
11. GLEW, S., STERN, P., DAVIDSON, J. and DYER, P., HLA antigens and cervical carcinoma. Nature (Lond.), 356, 22 (1992).
12. GREGOIRE, L., LAWRENCE, W., KUKURUGA, D., EISENBREY, A. and LANCASTER, W., Association between HLA-DQB1 alleles and risk for cervical cancer in African American women. Int. J. Cancer, 57, 504-507 (1995).
13. HAN, R., BREITBURD, F., MARCHE, P. and ORTH, G., Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class-II genes. Nature (Lond.), 356, 66-68 (1992).
14. HEINO, P., EKLUND, C., FREDRIKSSON-SHANAZARIAN, V., GOLDMAN, S., SCHILLER, J.T. and DILLNER, J., Association of serum immunoglobulin G antibodies against human papillomavirus type-16 capsids with anal epidermal carcinoma. J. nat. Cancer Inst., 87, 437-440 (1995).
15. HELLAND, Å, BØRRENSEN, A., KœRN, J., RØNNINGEN, K. and THORSBY, E., HLA and cervical carcinoma. Nature (Land.), 356, 23 (1992).
16. HELLAND, Å, BØRRENSEN, A-L., KRISTENSEN, G. and RØNNINGEN, K., DQA1 and DQB1 genes in patients with squamous-cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. Cancer Epidemiol. Biomarken Prevent., 3, 479-486 (1994).
17. HILDESHEIM, A., SCHIFFMAN, M., GRAVITT, P., GLASS, A., GREER, C., ZHANG, T., SCOTT, D., RUSH, B., LAWLER, P., SHERMAN, M.E., KURMAN, R.J. and MANOS, M.M., Persistence of type-specific human papilloma virus infection among cytologically normal women. J. infect. Dis., 169, 235-240 (1994).
18. KIRNBAUER, R., HUBBERT, N.L., WHEELER, C.M., BECKER, T.M., LOWY, D.R. and SCHILLER, J.T., A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 494-498 (1994).
19. LU, S.J., DAY, N.E. and DEGOS, L., Linkage to nasopharyngeal carcinoma susceptibility locus to HLA region. Nature (Land.), 346, 470-471 (1990).
20. NAWA, A., NISHIYAMA, Y., KOBAYASHI, T., WAKAHARA, Y., OKAMOTO, T., KIKKAWA, F., SUGANUMA, N., GOTO, S., KUZUYA, K. and TOMODA, Y., Association of HLA-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer, 75, 518-521 (1995).
21. OLERUP, O. and ZETTEQRUIST, H., HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donorrecipient matching in cadaveric transplantation. Tiss. Antigens, 39, 225-235 (1992).
22. SANJEEVI, C.B., SESHIAH, V., MÖLLER, E. and OLERUP, O., Different genetic background for type-1 diabetes and malnutrition-related diabetes in South Indians. Diabetologia, 35, 283-286 (1992).
23. SANJEEVI, C.B., ZEIDLER, A., SHAW, S., ROTTER, J., NEPOM, G.T., COSTIN, G., RAFFEL, L., EASTMAN, S., KOCKUM, I., WASSMUTH, R. and LERNMARK, Å., Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus. Tiss. Antigens, 38, 72-77 (1993).
24. SCHIFFMAN, M., BAUER, H., HOOVER, R., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, S. and MANOS, M.M., Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. nat. Cancer Inst., 85, 958-964 (1993).
25. WANK, R., MEULEN, J., LAUNDE, J., EBERHARDT, H.-C. and PAWLITA, M., Cervical intraepithelial neoplasia, cervical carcinoma and risk for patients with HLA-DQB1*0602, *0301, *0303. Lancet, 341, 1215 (1993).
26. WANK, R., SCHENDEL, D. and THOMSSEN, C., HLA antigens and cervical carcinoma. Nature (Land.), 356, 22-23 (1992).
27. WANK, R. and THOMSSEN, C., High risk for squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature (LonD.), 352, 723-725 (1991).
28. ZUR HAUSEN, H., Viruses in human cancers. Science (Wash.), 254, 1167-1173 (1991).